These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 37694947

  • 1. Association between anti-endothelial antigen antibodies and allograft rejection in kidney transplantation.
    Lee HJ, Shin KH, Kim IY, Choi BH, Kim HH.
    J Clin Lab Anal; 2023 Aug; 37(15-16):e24961. PubMed ID: 37694947
    [Abstract] [Full Text] [Related]

  • 2. Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients.
    Liu C, Kang ZY, Yin Z, Xiao Y, Liu W, Zhao Y, Li DH.
    Transpl Immunol; 2022 Oct; 74():101674. PubMed ID: 35901953
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome.
    El Band JEK, Llorente S, Martinez-Garcia P, Alfaro R, Jimenez-Coll V, Boix F, Galián JA, Martinez-Banaclocha H, Botella C, Moya-Quiles MR, Minguela A, Legaz I, Muro M.
    Curr Protein Pept Sci; 2021 Oct; 22(10):745-757. PubMed ID: 34967284
    [Abstract] [Full Text] [Related]

  • 4. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection.
    Lee H, Kim JI, Moon IS, Chung BH, Yang CW, Kim Y, Han K, Oh EJ.
    Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439
    [Abstract] [Full Text] [Related]

  • 5. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C, Viglietti D, Bouatou Y, Philippe A, Pievani D, Aubert O, Duong Van Huyen JP, Taupin JL, Glotz D, Legendre C, Loupy A, Halloran PF, Dragun D.
    Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
    [Abstract] [Full Text] [Related]

  • 6. Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Kamińska D, Zmonarski S, Mazanowska O, Krajewska M, Bartoszek D, Zabińska M, Myszka M, Kamińska M, Hałoń A, Dawiskiba T, Szyber P, Sas A, Klinger M.
    Transplant Proc; 2014 Oct; 46(8):2618-21. PubMed ID: 25380879
    [Abstract] [Full Text] [Related]

  • 7. A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.
    Reinsmoen NL, Mirocha J, Ensor CR, Marrari M, Chaux G, Levine DJ, Zhang X, Zeevi A.
    Transplantation; 2017 Jun; 101(6):1215-1221. PubMed ID: 27973391
    [Abstract] [Full Text] [Related]

  • 8. Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes.
    Pearl MH, Chen L, Zuckerman JE, Weng PL, Chambers ET, Zhang Q, Reed EF.
    Transplantation; 2024 Jan 01; 108(1):276-283. PubMed ID: 37527494
    [Abstract] [Full Text] [Related]

  • 9. The role of endothelin II type A receptor (ETAR) in transplant injury.
    Nowańska K, Wiśnicki K, Kuriata-Kordek M, Krajewska M, Banasik M.
    Transpl Immunol; 2022 Feb 01; 70():101505. PubMed ID: 34793957
    [Abstract] [Full Text] [Related]

  • 10. Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies?
    Irure J, López-Hoyos M, Rodrigo E, Gómez-Román J, Ruiz JC, Arias M, San Segundo D.
    Transplant Proc; 2016 Nov 01; 48(9):2888-2890. PubMed ID: 27932099
    [Abstract] [Full Text] [Related]

  • 11. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Krajewska M, Mazanowska O, Kamińska D, Bartoszek D, Zabińska M, Myszka M, Nowakowska B, Hałoń A, Dawiskiba T, Chudoba P, Klinger M.
    Transpl Immunol; 2014 Jan 01; 30(1):24-9. PubMed ID: 24184747
    [Abstract] [Full Text] [Related]

  • 12. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin JL, Duong Van-Huyen JP, Loupy A, Lefaucheur C.
    Kidney Int; 2017 Sep 01; 92(3):729-742. PubMed ID: 28554738
    [Abstract] [Full Text] [Related]

  • 13. Humoral immunity in hand transplantation: anti-HLA and non-HLA response.
    Banasik M, Jabłecki J, Boratyńska M, Kamińska D, Kościelska-Kasprzak K, Bartoszek D, Chełmoński A, Hałoń A, Baran W, Klinger M.
    Hum Immunol; 2014 Aug 01; 75(8):859-62. PubMed ID: 24952209
    [Abstract] [Full Text] [Related]

  • 14. Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients.
    Fichtner A, Süsal C, Höcker B, Rieger S, Waldherr R, Westhoff JH, Sander A, Dragun D, Tönshoff B.
    Pediatr Nephrol; 2021 Aug 01; 36(8):2473-2484. PubMed ID: 33759004
    [Abstract] [Full Text] [Related]

  • 15. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A, Van Loon E, Lerut E, Coemans M, Callemeyn J, Daniëls L, Kerkhofs J, Koshy P, Kuypers D, Lamarthée B, Sprangers B, Tinel C, Van Craenenbroeck AH, Van Sandt V, Emonds MP, Naesens M.
    Am J Kidney Dis; 2022 Dec 01; 80(6):718-729.e1. PubMed ID: 35690154
    [Abstract] [Full Text] [Related]

  • 16. Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation.
    Pearl MH, Chen L, ElChaki R, Elashoff D, Gjertson DW, Rossetti M, Weng PL, Zhang Q, Reed EF, Chambers ET.
    Kidney Int Rep; 2020 Nov 01; 5(11):1925-1936. PubMed ID: 33163713
    [Abstract] [Full Text] [Related]

  • 17. Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies.
    Philogene MC, Bagnasco S, Kraus ES, Montgomery RA, Dragun D, Leffell MS, Zachary AA, Jackson AM.
    Transplantation; 2017 Mar 01; 101(3):608-615. PubMed ID: 27222934
    [Abstract] [Full Text] [Related]

  • 18. Long-term follow-up of non-HLA and anti-HLA antibodies: incidence and importance in renal transplantation.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Mazanowska O, Bartoszek D, Zabińska M, Myszka M, Nowakowska B, Hałoń A, Szyber P, Patrzałek D, Klinger M.
    Transplant Proc; 2013 May 01; 45(4):1462-5. PubMed ID: 23726597
    [Abstract] [Full Text] [Related]

  • 19. Antibodies Against ARHGDIB and ARHGDIB Gene Expression Associate With Kidney Allograft Outcome.
    Senev A, Otten HG, Kamburova EG, Callemeyn J, Lerut E, Van Sandt V, Kuypers D, Emonds MP, Naesens M.
    Transplantation; 2020 Jul 01; 104(7):1462-1471. PubMed ID: 31651716
    [Abstract] [Full Text] [Related]

  • 20. Sox7 is involved in antibody-dependent endothelial cell activation and renal allograft injury via the Jagged1-Notch1 pathway.
    Qin Y, Sun B, Zhang F, Wang Y, Shen B, Liu Y, Guo Y, Fan Y, Qiu J.
    Exp Cell Res; 2019 Feb 15; 375(2):20-27. PubMed ID: 30639059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.